Current issue #5, 2018

Drug resales by distributors account for 15% of the market size

Drug manufacturers, pharmacies, and distributors are well aware that there is a resale market within the pharmacy sector. However, this has been backroom dealing so far, and market players had to put up with the unfair practices. Analysts know, too, that drug leakage through secondary distribution channels has been practiceds for at least three years. Now it looks like the situation has ventured too far, and experts decided to lance the pharmacy market «abscess» in the public.

[PharmVestnik # 05, 13/02/2018, p. 1, cont’d p. 7]

// Pharma Retailing

71% of chain pharmacies have marketing contracts with manufacturers

In early February, the ski resort Krasnaya Polyana near Sochi was the venue of the 2^nd conference “PROjections of the Future” focusing on mutual benefits of marketing contracts. The conference was hosted by Bionika Group, PharmVestnik, and KST Interforum. Pharmaceutical manufacturers and pharmacy sector players openly discussed the changing relationships between the market players seeking to establish a foothold.

[PharmVestnik # 05, 13/02/2018, pp. 2-3]

// Pharma Industry – General

<...